| 000 | 01038 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250516073255.0 | ||
| 264 | 0 | _c20120629 | |
| 008 | 201206s 0 0 eng d | ||
| 022 | _a1949-2553 | ||
| 024 | 7 |
_a10.18632/oncotarget.383 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJohnsen, John Inge | |
| 245 | 0 | 0 |
_aIs human cytomegalovirus a target in cancer therapy? _h[electronic resource] |
| 260 |
_bOncotarget _cDec 2011 |
||
| 300 |
_a1329-38 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 |
_aCytomegalovirus _xdrug effects |
| 650 | 0 | 4 |
_aCytomegalovirus Infections _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aNeoplastic Stem Cells _xvirology |
| 650 | 0 | 4 | _aTumor Microenvironment |
| 700 | 1 | _aBaryawno, Ninib | |
| 700 | 1 | _aSöderberg-Nauclér, Cecilia | |
| 773 | 0 |
_tOncotarget _gvol. 2 _gno. 12 _gp. 1329-38 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.18632/oncotarget.383 _zAvailable from publisher's website |
| 999 |
_c21461999 _d21461999 |
||